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Immunochemical techniques are complementary tools to modern analytical requirements. These methods 
rely on the production of immunoreagents with adequate binding properties. In the present study, a 
rationally-designed functionalized derivative of pyrimethanil – a modern anilinopyrimidine fungicide – 
was synthesized in order to generate for the first time high-affinity and selective antibodies to this 10 
xenobiotic. A single coupling procedure – based on hapten activation using N,N’-disuccinimidyl 
carbonate and purification of the active ester  – was followed to prepare both immunizing and assay 
conjugates. Polyclonal antibodies were produced and characterized by enzyme-linked immunosorbent 
assay (ELISA) in four alternative formats: one indirect and three direct competitive procedures. The 
selected immunoassay displayed a limit of detection of 0.024 µg L−1, far lower than the official maximum 15 
residue limits and close similar to the sensitivity of regular instrumental assays. This ELISA was shown 
to be robust to buffer changes and tolerant to the presence of little amounts of methanol, ethanol and 
acetonitrile. Finally, the developed assay was applied to the analysis of pyrimethanil in carrot juice 
samples, and a limit of quantification of 0.040 mg L−1 was determined.
Introduction 20 
The development and application of bioanalytical techniques to 
xenobiotic determination has meant a step forward to attaining 
more rapid, simple and inexpensive methodologies for new or 
alternative analytical applications, such as on-site environmental 
monitoring, food safety crises and private quality controls. 25 
Particularly, immunochemical assays, which are based on the 
specific antibody–antigen interaction, have been developed for 
the analysis of a large list of chemical substances, including 
antibiotics,1,2 hormones3, drugs of abuse,4 mycotoxins,5,6 
pesticides,7,8 packaging components,9,10 industrial contaminants,11 30 
etc. Due to the haptenic character of those small chemical 
compounds, immunoassays need to be performed in competitive 
mode. The most common immunoanalytical method is the 
enzyme-linked immunosorbent assay (ELISA) which can be 
arranged in different formats. At least, three immunoreagents are 35 
required in order to develop a competitive ELISA; that is, the 
immunizing bioconjugate, the antibody and the assay 
bioconjugate. Hapten design and antibody generation are key 
steps for immunoassay development. Assay sensitivity directly 
depends on the affinity of the antibody towards the target analyte, 40 
and linker derivatization site strongly determines antibody 
specificity. 
 Pyrimethanil is a fungicide belonging to the anilinopyrimidine 
class of pesticides that also includes cyprodinil and mepanipyrim 
(Fig. 1). It inhibits the secretion of hydrolytic enzymes that are 45 
required during the infection process, so it blocks the ability of 
fungi to degrade and digest the infected tissues, thus stopping 
penetration and development of the disease, even though 
inhibition of methionine biosynthesis in fungal cells has also been 
suggested.12 Pyrimethanil has low acute toxicity in mammals, 50 
however long-term studies showed certain toxicity in mice, rats, 
dogs and aquatic organisms. It was found that very little 
metabolism occurs in plants, so the major residue for plant 
commodities has been defined as the pesticide itself.13 This 
fungicide was incorporated in 2006 into Annex I of the European 55 
Council Directive 91/414/EEC,14 listing the approved active 
substances for plant protection in the EU. It is extensively used to 
control fungal attacks on ornamentals, fruits and vegetables, 
including roots and tubers, and consequently residues of 
pyrimethanil are frequently found in foodstuffs.15 Maximum 60 
residue limits of this xenobiotic have been established in the EU 
at 10 mg kg−1 for citrus, 5 mg kg−1 for most fruits and 1 mg kg−1 
for most vegetables.16 
 Regular analytical procedures for pyrimethanil consist of 
organic solvent extraction (acetone or methanol), clean-up and 65 
analysis by either gas chromatography (GC), with a mass 
spectrometer detector (m/z 198), or by high-performance liquid 
N
N
H
N N
N
H
N N
N
H
N
Fig. 1. Chemical structures of the three anilinopyrimidine fungicides.
From left to right: pyrimethanil, cyprodinil and mepanipyrim. 
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chromatography (HPLC) with an ultraviolet detector. Limits of 
quantification between 0.02 and 0.05 mg kg−1 were demonstrated 
for fruits and vegetables by such methods.17 Those are highly 
powerful techniques for surveillance and control programs due to 
their low limits of detection and high capacity for multiresidue 5 
analysis. 
 Nowadays, scientific analytical research is going on in order to 
develop new analytical methodologies for pyrimethanil, and 
several articles have been published recently concerning 
instrumental methods.18–20 However, to our knowledge, no 10 
articles have been published so far regarding the production of 
immunoreagents and the development of immunoassays for this 
xenobiotic. The aim of our study was the synthesis of a 
functionalized derivative of pyrimethanil suitable for generating 
high-affinity and selective antibodies for this compound. 15 
Moreover, these antibodies and bioconjugates were applied to the 
development of sensitive immunoassays for pyrimethanil 
analysis. 
Experimental 
Chemicals and instruments 20 
Pyrimethanil [N-(4,6-dimethylpyrimidin-2-yl)aniline] (CAS 
registry number 53112-28-0; MW 199.25 g/mol) and other 
fungicide standards were purchased either from Riedel-de-Haën 
(Selzee, Germany) or Dr. Ehrenstorfer (Augsburg, Germany). 
Pesticide standards were prepared as concentrated solutions in 25 
anhydrous N,N-dimethylformamide (DMF) and were kept at 
−20 °C in amber glass vials. 6-(4-Aminophenyl)hexanoic acid (2) 
was prepared from 1-iodo-4-nitrobenzene and hex-5-ynoic acid.21 
Other reagents were acquired from commercial sources and used 
without purification. Reactions were monitored with the aid of 30 
thin-layer chromatography using 0.25 mm pre-coated silica gel 
plates. Visualization was carried out with UV light and a 50% 
(v/v) aqueous ceric or ammonium molybdate solution. Flash 
column chromatography was carried out with the indicated 
solvents on silica gel 60 (particle size 0.040−0.063 mm). All 35 
melting points were determined using a Kofler hot-stage 
apparatus and are uncorrected. NMR spectra were recorded on a 
Bruker AC-300 spectrometer (300.13 MHz for 1H and 75.47 
MHz for 13C), and they were referenced to residual solvent 
protons in the 1H NMR spectra (7.15 and 2.50 ppm for C6D6 and 40 
DMSO-d6, respectively) and to solvent carbons in the 
13C NMR 
spectra (128.0 and 39.43 ppm for C6D6 and DMSO-d6, 
respectively). Infrared (IR) spectra were measured using a Nicolet 
Avatar 320 spectrometer. Mass spectra (MS) and high-resolution 
mass spectra (HRMS) were recorded in the electron impact mode 45 
(EI, 70 eV) using a Micromass VG Autospec spectrometer. The 
most stable conformation of pyrimethanil was calculated using 
CONFLEX with MM3 molecular mechanics to systematically 
search for low-energy conformers, followed by geometry 
optimization in MOPAC using PM3 parameters (CAChe 50 
WorkSystem Pro, version 7.5.0.85). 
 Horseradish peroxidase (HRP), ovalbumin (OVA) and 
o-phenylenediamine were purchased from Sigma-Aldrich 
(Madrid, Spain). Bovine serum albumin (BSA) fraction V was 
purchased from Roche Applied Science (Mannheim, Germany). 55 
Sephadex G-25 HiTrap Desalting columns from GE Healthcare 
(Uppsala, Sweden) were used for conjugate purification. Capture 
goat anti-rabbit immunoglobulin (GAR) polyclonal antibody was 
acquired to Rockland Immunochemicals (Gilberstville, PA, USA) 
and goat anti-rabbit immunoglobulin polyclonal antibody 60 
conjugated to peroxidase (GAR–HRP) was from BioRad 
(Hercules, CA, USA). Foetal bovine serum (FBS) and Freund’s 
adjuvants were from Sigma-Aldrich (Madrid, Spain). Costar flat-
bottom high-binding 96-well polystyrene ELISA plates were 
from Corning (Corning, NY, USA). UV-visible spectra and 65 
ELISA absorbances were read with a PowerWave HT from 
BioTek Instruments (Winooski, VT, USA). Microwells were 
washed with an ELx405 microplate washer also from BioTek 
Instruments. 
Buffers and solutions 70 
a) CB, 50 mM sodium carbonate–bicarbonate buffer, pH 9.6; b) 
enzyme substrate buffer, 25 mM sodium citrate and 62 mM 
sodium phosphate buffer, pH 5.4; c) PB, 100 mM sodium 
phosphate buffer, pH 7.4; d) PBS, 10 mM sodium phosphate 
buffer, pH 7.4, with 140 mM NaCl; e) PBST, PBS containing 75 
0.05% (v/v) Tween 20; and f) washing solution, 150 mM NaCl 
containing 0.05% (v/v) Tween 20. 
Hapten preparation, activation and purification 
Hapten PMp6 [6-(4-(4,6-dimethylpyrimidin-2-ylamino)phenyl) 
hexanoic acid (3)] was prepared as schematized in Fig. 2. A 80 
mixture of 2-chloro-4,6-dimethylpyrimidine (1, 142.8 mg, 1.00 
mmol) and 6-(4-aminophenyl)hexanoic acid (2, 207 mg, 1.00 
mmol) in anhydrous 1,4-dioxane (5 mL) was heated at reflux 
with stirring for 30 h under nitrogen atmosphere. After this time, 
the mixture was cooled to room temperature (rt) and concentrated 85 
to dryness under reduced pressure. The obtained residue was 
dissolved in approximately 0.5 mL of formic acid and the product 
precipitated by slow addition of water (approximately 3 mL). The 
precipitate was filtered off, washed several times with cold water 
and dried under vacuum to afford hapten PMp6 (3) as a white 90 
solid (235 mg, 75%). Mp. 180–183 °C (crystallized from DMSO-
H2O); 
1H NMR (300 MHz, DMSO-d6) δ (ppm) 11.98 (1H, br s, 
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Fig. 2. Schematic representation of the synthesis and activation of hapten PMp6. DSC stands for N,N’-disuccinimidyl carbonate. 
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COOH), 9.33 (1H, s, N-H), 7.67 (2H, d, J = 8.4 Hz, H-2/H-6 Ph), 
7.06 (2H, d, J = 8.4 Hz, H-3/H-5 Ph), 6.58 (1H, s, H-5 Pyrim), 
2.47 (2H, t, J = 7.5 Hz, H-6), 2.29 (6H, s, 2×Me), 2.19 (2H, t, J = 
7.3 Hz, H-2), 1.52 (4H, m, H-3 and H-5), 1.28 (2H, m, H-4); 13C 
NMR (75 MHz, DMSO-d6) δ (ppm) 174.4 (C-1), 166.8 (C-4 and 5 
C-6 Pyrim), 159.7 (C-2 Pyrim), 138.5 (C-4 Ph), 134.5 (C-1 Ph), 
128.1 (C-3/C-5 Ph), 118.5 (C-2/C-6 Ph), 110.6 (C-5 Pyrim), 34.3 
(C-6), 33.6 (C-2), 30.8 (C-5), 28.1 (C-4), 24.3 (C-3), 23.4 
(2×Me); IR (KBr) vmax/cm
−1 3295, 3202, 3125, 3082, 2918, 2847, 
1698, 1618, 1585, 1547, 1410, 1377, 1274, 842, 733, 634, 547, 10 
504; MS (EI, 70 eV) m/z (%) 313 (M+, 45), 312 (9), 238 (3), 226 
(5), 213 (7), 212 (100), 211 (4); HRMS, m/z required for 
C18H23N3O2 313.17903, found 313.17896. 
 Hapten activation was readily performed using DSC, and the 
corresponding N-succinimidyl ester was easily purified. Briefly, 15 
hapten PMp6 (3, 32.1 mg, 0.102 mmol) and DSC (34 mg, 0.133 
mmol, 1.3 equiv.) were dissolved in dry CH3CN (1 mL) under 
nitrogen atmosphere. Next, Et3N (54 µL, 0.387 mmol, 3.8 equiv.) 
was added and the reaction mixture was stirred at rt for 15 h. The 
solution was diluted with chloroform, washed with an aqueous 20 
saturated solution of NaHCO3 and brine and then dried over 
anhydrous Na2SO4. Flash column chromatography of the residue 
that was left after evaporation of the solvent, using chloroform as 
eluent, gave the pure N-succinimidyl ester of hapten PMp6 (4, 34 
mg, 82%) as an oil. 1H NMR (300 MHz, C6D6) δ (ppm) 7.64 (2H, 25 
d, J = 8.3 Hz, H-2/H-6 Ph), 7.31 (1H, s, N-H), 7.00 (2H, d, J = 
8.3 Hz, H-3/H-5 Ph), 5.95 (1H, s, H-5 Pyrim), 2.34 (2H, t, J = 7.6 
Hz, H-6), 2.10 (6H, s, 2×Me), 2.08 (2H, t, J = 7.6 Hz, H-2), 1.58 
(4H, br s, COCH2CH2CO), 1.40 (2H, m, H-5), 1.31 (2H, m, H-3), 
1.05 (2H, m, H-4); 13C NMR (75 MHz, C6D6) δ (ppm) 169.1 (C-30 
1), 168.9 (CONHCO), 167.4 (C-4 and C-6 Pyrim), 160.7 (C-2 
Pyrim), 138.6 (C-4 Ph), 135.5 (C-1 Ph), 128.9 (C-3/C-5 Ph), 
119.5 (C-2/C-6 Ph), 111.3 (C-5 Pyrim), 35.2 (C-6), 31.2(C-2), 
30.9 (C-5), 28.4 (C-4), 25.3 (COCH2CH2CO) 24.6 (C-3), 23.8 
(2×Me). 35 
Conjugate preparation 
Immunizing conjugates were prepared using BSA as carrier, 
whereas OVA and HRP were employed in the preparation of 
competing antigens for indirect and direct assays, respectively. 
Conjugation was performed with gentle stirring in amber glass 40 
vials. Conjugates were purified by size exclusion chromatography 
using 3 serially-connected HiTrap columns and PB as eluent, and 
they were stored frozen at −20 °C. The degree of conjugation was 
estimated from absorbance measurements at 280 nm of the 
conjugate assuming that the molar absorptions of both, the hapten 45 
and the protein, did not change upon conjugation.  
 To prepare BSA–PMp6 conjugate, 200 µL of a 50 mM 
solution of the N-succinimidyl ester of PMp6 (4) in anhydrous 
DMF was added drop wise over a 15 mg mL−1 BSA solution (2 
mL) in CB and the mixture was gently stirred at rt during 4 h. 50 
After purification, the collected volume was brought to 30 mL 
with PB.  
 As coating antigens, three OVA conjugates were prepared with 
different MRs. One hundred microlitres of a solution containing 
10, 5 or 1 µmol of activated PMp6 (4) in DMF was slowly added 55 
over a 2 mL OVA solution (15 mg mL−1) in CB under stirring. 
The mixture was reacted during 2.5 h at rt and the conjugate was 
purified as described above. The pooled fractions containing the 
conjugate were brought to 30 mL using PB and stored frozen at 
−20 °C.  60 
 For direct assays, two tracer conjugates were prepared with 
different MRs. The same conjugation procedure as for the OVA 
conjugates was followed, except that a 1.0 mL HRP solution (2.2 
mg mL−1) was employed and 1 or 0.5 µmol of activated PMp6 (4) 
in 100 µL of DMF was added.  65 
Antibody generation 
Animal manipulation was carried out in compliance with Spanish 
laws and guidelines (RD1201/2005 and law 32/2007) and 
according to European Directive 2010/63/EU concerning 
protection of animals used for scientific purposes. Two female 70 
New Zealand white rabbits were immunized following standard 
protocols as described in previous publications.22 Briefly, 0.3 mg 
of BSA–PMp6 conjugate in 1 mL of a 1:1 mixture of PB and 
complete (for first dose) or incomplete (for additional doses) 
Freund’s adjuvant was used as immunogen. Animals were 75 
boosted three times at 21-day intervals. Whole blood was 
collected from the ear vein of the rabbits and by intracardiac 
puncture 10 days after the fourth injection. Blood samples were 
allowed to coagulate overnight at 4 °C. Then, the serum was 
separated by centrifugation and antibodies were precipitated 80 
twice with a solution of saturated ammonium sulphate. 
Precipitates were stored at 4 °C.  
Conjugate-coated indirect competitive assays 
Coating was performed with 100 µL per well of OVA conjugate 
solution in CB by overnight incubation at rt. Each microwell was 85 
washed four times with washing solution and received, 
afterwards, 50 µL of pyrimethanil standard solution in PBS plus 
50 µL of antibody dilution in PBST. The reaction was allowed to 
reach equilibrium (1 h) and plates were washed again. Next, 100 
µL per well of a 104-fold dilution of GAR–HRP conjugate in 90 
PBST containing 10% FBS was added, and plates were incubated 
1 h at rt. Signal was produced by addition of 100 µL per well of 
freshly prepared 2 mg mL−1 o-phenylenediamine solution 
containing 0.012% (v/v) H2O2 in substrate buffer. The enzymatic 
reaction was stopped after 10 min at rt with 100 µL per well of 95 
2.5 M sulphuric acid. The absorbance was immediately read at 
492 nm with a reference wavelength at 650 nm. 
Antibody-coated direct competitive assays 
Plates were coated overnight at rt with 100 µL per well of 
antibody dilution in CB. After washing as described above, 50 µL 100 
of analyte standard solution in PBS plus 50 µL of HRP–PMp6 
tracer conjugate in PBST were added to each well. The 
immunological reaction was run during 1 h at rt, and then plates 
were washed as usually. Signal was developed and read as 
explained for the previous format. 105 
One-step and two-step capture-antibody direct competitive 
assays 
Coating was done by overnight incubation at rt with 100 µL per 
well of a 1 µg mL−1 solution of GAR in CB. After each step, 
microwells were washed four times with washing solution. These 110 
assays were performed at rt following either a one-step or a two-
step procedure. If the assay was performed in two steps, a 100 µL 
dilution of primary antibody in PBST was employed and, after 
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washing, the competitive reaction was done as described for the 
previous direct assay. In one-step assays, each microwell received 
sequentially the three reagents: first, 50 µL of pyrimethanil 
standard solution in PBS; second, 25 µL of tracer conjugate in 
PBST; and third, 25 µL of antibody dilution in PBST. Signal was 5 
developed and read as in other ELISA formats. 
Solvent, pH and ionic strength studies 
Pyrimethanil standard curves were prepared in Milli-Q water 
containing between 0.5 and 10% (v/v) methanol, ethanol or 
acetonitrile, and immunoreagents were prepared in 2×PBS 10 
containing 0.05% (v/v) Tween 20. The influence of buffer ionic 
strength and pH was evaluated at rt following a central composite 
design that involved a total of 39 randomized buffer studies. The 
ionic strength values of the evaluated buffers ranged between 50 
and 300 mM, and the studied pH values were between 5.5 and 15 
9.5. Buffers were prepared from a 40 mM trisodium citrate, 40 
mM disodium hydrogen phosphate and 40 mM Tris solution as 
previously published,23 so three buffer systems were enclosed 
(citrate, pKa2 = 4.8 and pKa3 = 6.4; phosphate, pKa2 = 7.2; and 
Tris, pKa = 8.1) with buffering capacities covering the whole 20 
range of assayed pH values. NaCl was employed to adjust the 
ionic strength in each case. Pyrimethanil standards were run in 
Milli-Q water and enzyme tracer solutions were prepared in each 
of the studied buffers containing 0.05% (v/v) Tween 20. Curve 
parameters were fitted, by a multiple regression equation, with 25 
the assayed pH and ionic strength values of the buffer using 
Minitab 14.1 software (Minitab Inc., State College, PA, USA). 
Standard curve and data processing 
Eight-point standard curves, including a blank (no analyte), were 
prepared by 10-fold serial dilution in PBS from a 4 mg mL−1 30 
pyrimethanil stock solution in anhydrous DMF. Experimental 
values were fitted to a four-parameter logistic equation using the 
SigmaPlot software package from SPSS Inc. (Chicago, IL, USA). 
Assay sensitivity was defined as the concentration of analyte 
affording a 50% inhibition (IC50) of the maximum absorbance 35 
(Amax) reached in the absence of analyte. Cross-reactivity (CR) 
was determined as the percentage value from the quotient 
between the IC50 value for pyrimethanil and the IC50 value for the 
corresponding analyte, both in molar concentration units. 
Sample analysis 40 
Commercial carrot juice was directly spiked using a pyrimethanil 
stock solution in DMF. Before ELISA, samples were properly 
diluted with Milli-Q water. 
Results and discussion 
Immunoreagent production 45 
Synthesis of hapten PMp6 (3) involved the aromatic nucleophilic 
substitution reaction of 4,6-dimethylpyrimidine (1) with 
6-(4-aminopheny)hexanoic acid (2), which occurred quite 
efficiently, without necessity of either acid o basic catalyst, by 
simple heating of both reactants in 1,4-dioxane at reflux (Fig. 2). 50 
Also, activation of the carboxyl moiety of hapten PMp6 (3) was 
easily achieved using DSC, a procedure that allowed us to obtain 
the N-succinimidyl ester derivative of the hapten, i.e. compound 
4, in high yield and purity. 
 A conformational analysis of pyrimethanil showed that it 55 
exists in a rapid equilibrium between several energetically similar 
extended conformations, all of them displaying a very small angle 
between the planes formed by the two aromatic rings. The 3D 
spatial representation of the electrostatic potential surface of the 
most stable conformation (43.818 kcal/mol) shows the nearly 60 
planar disposition of the molecular framework and electron 
density distribution, which evidences the concentration of 
negative charge density on the nearest surrounding of the 
nitrogen atoms (Fig. 3). The prepared hapten (PMp6) preserves 
the complete skeleton of pyrimethanil, and no or little 65 
conformational or electronic alterations of the parent 
pyrimethanil framework could be reasonably expected. 
Moreover, optimal display of the relevant immunogenic moieties 
of this anilinopyrimidine is favored because of the distal position 
of the spacer arm with respect to the pyrimidine ring. 70 
 The availability of the activated hapten in purified form 
allowed us to readily prepare both the immunizing and the assay 
conjugates using the same coupling procedure. With such hapten 
activation strategy, conjugates to OVA and HRP with precise 
hapten-to-protein ratios could be readily prepared. MRs were 75 
estimated after conjugate purification considering a molar 
extinction coefficient for hapten PMp6 of 14.9 mM−1 cm−1 
(determined at 280 nm in PB). The calculated MR of the 
immunogen was 13; those of the three OVA conjugates were 2, 4 
and 7; and those of the two tracer conjugates were 2 and 3. 80 
 Two polyclonal antibodies, namely rPMp6#1 and rPMp6#2, 
were generated with BSA–PMp6 as immunizing conjugate. A 
standard immunization process was applied, so whole blood was 
collected 2.5 months after the first injection. Antibodies were 
used in a partially purified form, i.e. first, antisera were separated 85 
by centrifugation and then, immunoglobulins were precipitated 
by salting out. The selectivity of the generated antibodies was 
checked by direct competitive homologous assays using as 
competitors (up to 10 µM) the two other anilinopyrimidine 
fungicides (cyprodinil and mepanipyrim). It was found that 90 
antibody rPMp6#1 was selective of pyrimethanil (CR < 0.1% for 
cyprodinil and mepanipyrim), whereas antibody rPMp6#2 
showed a higher recognition of cyprodinil (CR = 21%) and 
mepanipyrim (CR = 5%). Other common agrochemicals 
(azoxystrobin, fenhexamid and boscalid) were also tested and 95 
they were not bound by any of the two antibodies. Despite the 
great molecular structure similarity of the three members of this 
Fig. 3. Electron density isosurface colored by electrostatic potential of 
the most stable conformation of pyrimethanil. The energy values [in 
atomic units (au)] at each color interface are: white−red, +0.09 au; 
red−yellow, +0.02 au; yellow−green, +0.01 au; green−light blue, 0.00 
au; light blue−dark blue, −0.01 au; dark blue−pink, −0.03 au; 
pink−violet, −0.06 au; where 1 au = 627.503 kcal/mol. Arrow 
indicates the spacer attachment site in hapten PMp6. 
Page 7 of 31 Analyst
 This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  5 
family (Fig. 1), one highly selective antibody was obtained. Since 
metabolism of pyrimethanil in plants is negligible13 and the 
antibody is highly specific, accurate measurements and no 
interferences from degradation products can be expected in 
vegetable analysis. However, results would be more uncertain 5 
with animal or environmental samples because metabolites and 
degradation products can exist.13 
Immunoassay characterization 
Four sorts of ELISA formats were studied using a checkerboard 
competitive approach in which a pyrimethanil standard curve 10 
(from 0.002 ng mL−1 to 2000 ng mL−1 plus a blank) was run in 
each plate column, and different concentrations of the involved 
immunoreagents were simultaneously evaluated in triplicate 
wells.  
Indirect assays 15 
 OVA–PMp6 conjugates with different MRs were employed for 
coating using solutions at three alternative concentrations (10, 
100 and 1000 ng mL−1), and six antibody dilutions were assayed 
ranging from 104 to 3×106 fold. Thus, a series of inhibition curves 
were obtained for each immunoreagent pair, from which the 20 
curve with an Amax value nearest to 1.0 was picked out. The main 
parameters of selected curves for each antibody–conjugate 
combination are listed in Table 1. As it can be observed, low 
slopes (below −0.6) were generally found. Signals at excess of 
analyte (2000 ng mL−1) were always below 10% of the Amax, so 25 
unspecific binding events were not noticed. It was seen that the 
two generated antibodies displayed high affinity to pyrimethanil. 
Also, as revealed from the results listed in Table 1, the IC50 
values of indirect assays could be improved by lowering either 
the coating conjugate concentration or the conjugate MR. 30 
Direct assays 
Checkerboard competitive studies were run in the direct ELISA 
format with plates coated using different antibody dilutions (from 
104 to 2×105 fold), and with solutions of varying concentrations 
of HRP–PMp6 (from 3 to 10 ng mL−1). In addition, two tracers 35 
with different MRs were assayed. The parameters of the 
inhibition curve with the Amax closest to 1.0 for each 
immunoreagent combination are listed in Table 2. As before, 
those curves showed near zero signals (around 0.01) under 
complete inhibition conditions. Lower IC50 values were found 40 
with antibody rPMp6#1, and a balance had to be reached between 
antibody and tracer concentrations in order to achieve the highest 
detectability. Compared to indirect assays, higher slopes (over 
−0.7 in most cases) and slightly better IC50 values were attained 
with this ELISA format. On the contrary, a lower MR of the 45 
enzyme conjugate did not show a clear influence over the 
sensitivity of the immunoassay. 
Capture-antibody assays 
Two additional competitive ELISA formats were evaluated using 
plates coated with a capture antibody specific of rabbit IgG 50 
(H+L). Assays were carried out in a one-step (antibody + tracer + 
Table 2 Curve parameters for antibody-coated direct competitive assays (n = 3) 
HRP–PMp6 
 Antibody 
 rPMp6#1  rPMp6#2 
MR Conc. (ng mL−1)a  Dil.b Amax Slope IC50 (ng mL
−1)  Dil. Amax Slope IC50 (ng mL
−1) 
3 10   5×104 0.98 −0.72 3.5  2×105 1.09 −0.79 9.8 
 5   3×104 1.10 −0.73 2.6  2×105 0.82 −0.80 6.0 
 3   2×104 1.17 −0.70 5.6  1×105 1.14 −0.68 4.7 
2 10   5×104 0.87 −0.75 3.2  2×105 0.87 −0.80 6.9 
 5   3×104 0.97 −0.76 2.4  1×105 1.24 −0.70 3.8 
 3   2×104 1.01 −0.70 2.3  1×105 0.93 −0.74 3.5 
a Concentration of HRP tracer in the assay. b Antibody dilution for coating. 
Table 1 Curve parameters for conjugate-coated indirect competitive assays (n = 3) 
OVA–PMp6 
 Antibody 
 rPMp6#1  rPMp6#2 
MR Conc. (ng mL−1)a  Dil.b Amax Slope IC50 (ng mL
−1)  Dil. Amax Slope IC50 (ng mL
−1) 
7 1000   n.a.c     n.a.    
 100   3×105 0.93 −0.49 8.4  1×106 0.96 −0.47 7.9 
 10   3×104 1.29 −0.53 6.2  1×105 1.25 −0.55 5.8 
4 1000   3×105 1.54 ---d ---  1×106 0.96 --- --- 
 100   3×105 1.03 −0.47 8.6  1×106 1.01 −0.55 9.6 
 10   3×104 1.39 −0.54 5.8  1×105 1.40 −0.54 6.3 
2 1000   3×105 1.35 --- ---  1×106 1.25 --- --- 
 100   1×105 1.12 −0.56 2.8  3×105 1.09 −0.57 4.5 
 10   1×104 0.56 −0.61 6.2  1×104 0.94 −0.58 8.5 
a Concentration of OVA conjugate solution used for coating. b Antibody dilution in the assay. c Not assayed. d Poor fitting due to weak inhibition. 
Table 3 Curve parameters for direct competitive assays using capture antibody and antibody rPMp6#1 (n = 3) 
HRP–PMp6 
Conc. (ng mL−1)a 
 Assay procedure 
 Two-step assay  One-step assay 
 Dil.b Amax Slope IC50 (ng mL
−1)  Dil. Amax Slope IC50 (ng mL
−1) 
10   1×105 1.16 −0.62 2.1  1×105 1.44 −0.65 1.7 
5   1×105 0.89 −0.63 1.1  1×105 0.91 −0.66 1.3 
3   5×104 0.92 −0.62 1.1  5×104 0.54 −0.73 3.6 
a Concentration of HRP tracer in the assay. Only the tracer with the lowest MR was employed. b Antibody dilution for coating.  
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Fig. 5. Variation of Amax and IC50 values of the two-step capture 
direct competitive immunoassay with antibody rPMp6#1 due to 
the presence of organic solvents in the reaction mixture. 
Fig. 4. Assay standard curve using the two-step capture direct 
ELISA format. Values are the mean of eight independent 
determinations. The mean Amax value was 0.82. Antibody 
rPMp6#1 was diluted 105 fold and the optimum assay 
concentration of HRP–PMp6 was 5 ng mL−1. 
Fig.  6. Influence of buffer conditions over the Amax and IC50 
values of the standard curve of the selected assay. Contour plots 
were obtained by a central composite design, taking PBST as the 
centre point, and consisting of a 2-level full factorial design (α = 
1.414) with 2 factors and 3 replicates, that included 12 cube, 12 
axial and 15 centre point data. 
sample) or a two-step mode (plates were washed after the capture 
reaction). One-step assays were performed with consecutive 
addition of standard, tracer and antibody solutions – in that order 
and with no previous incubation of the primary antibody with the 
analyte or the capture antibody. In two-step assays, 30-min 5 
incubation time was found to be sufficient for the capture step to 
reach equilibrium. Again, checkerboard competitive assays were 
carried out using different concentrations of primary antibody 
(rPMp6#1) and tracer conjugate (MR = 2) in the presence of a 
standard curve of pyrimethanil. Both capture-assay formats (one-10 
step or two-step) gave equivalent results (Table 3). Curve slopes 
between −0.6 and −0.7 were obtained, and near zero signals were 
always found at high analyte concentrations. The lowest IC50 
value (1.1 ng mL−1) was achieved with the two-step assay. That 
immunoassay, the standard curve of which can be seen in Fig. 4, 15 
afforded a limit of detection (IC10) of 0.024 ng mL
−1, so it was 
selected for further characterization. 
Influence of solvents and buffer conditions 
The selected two-step capture-antibody direct competitive ELISA 
using rPMp6#1 as specific antibody for pyrimethanil and the 20 
tracer conjugate with MR = 2, as described in Fig. 4, was 
employed in these studies. Influence of solvent contents (from 
0.5% to 10%) over the Amax and IC50 values of the standard curve 
was investigated. Three solvents (methanol, ethanol and 
acetonitrile) which are commonly employed for direct pesticide 25 
extraction or in the QuEChERS technique24 were evaluated. As 
shown in Fig. 5, those solvents were quite well tolerated in the 
studied solvent concentration range, since up to 10% (v/v) solvent 
contents did not modify the maximum signal and just 3-fold 
higher IC50 values were obtained.  30 
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Fig. 7. Matrix effects of carrot juice over the standard curve of 
the developed capture direct immunoassay for pyrimethanil. 
 A rigorous approach was applied in order to assess the 
influence of pH and ionic strength over the main standard curve 
parameters. A complex buffer system (citrate–phosphate–Tris) 
was constructed so as to cover a wide range of pH values 
(from5.5 to 9.5). Tween 20 was added to each buffer and the 5 
ionic strength was corrected with NaCl to keep it constant, so 
only one factor (either the pH or the ionic strength) changed at a 
time. Moreover, the employed multiparametric strategy for data 
treatment with a full factorial design afforded a bidimensional 
picture showing changes of Amax and IC50 values as functions of 10 
pH and ionic strength simultaneously (Fig. 6). Thus, it could 
easily be observed that the selected immunoassay was pretty 
robust to pH and ionic strength, and that the highest Amax and 
optimum IC50 values were obtained around PBS-equivalent ionic 
strength (I = 162 mM at 25°C) and neutral pH conditions; that is, 15 
the central point of the applied factorial design. 
Pyrimethanil analysis 
Carrot juice was selected as a model commodity to evaluate the 
applicability of the developed immunoassay. First, pyrimethanil 
competitive assays were carried out in buffer containing different 20 
juice proportions to determine the minimum dilution that was 
required to minimize matrix effects. As seen in Fig. 7, the 
standard curve that was run in 50-fold diluted carrot juice was 
nearly indistinguishable from that run in buffer. Accordingly, 
recovery studies were undertaken with the developed ELISA by 25 
analyzing carrot juice samples spiked with known concentrations 
of pyrimethanil. As seen in Table 4, this competitive ELISA 
could measure pyrimethanil from 0.04 to 4 µg mL−1 in carrot 
juice, thus showing a limit of quantification comparable to those 
reported for GC/MS and HPLC/UV.17  30 
Conclusions 
Pyrimethanil residues are commonly found in environmental and 
food samples, so development of innovative analytical 
approaches is demanded. In this study, the first specific 
antibodies and bioconjugates to this pesticide have been produced 35 
and immunoassays have been developed for pyrimethanil 
bioanalysis in the low nanogram per millilitre range. It was 
shown that lower hapten-to-protein ratios can help to improve 
assay detectability in indirect format ELISAs. Purification of the 
activated hapten allowed us to employ the same protein coupling 40 
strategy for immunizing and assay conjugates with no impact on 
background signals commonly found with polyclonal antibodies. 
Slopes at the inflection point of standard curves were slightly 
steeper with direct format assays. The selected ELISA in the 
capture-antibody direct assay format with a two-step procedure 45 
was characterized, and it was applied to the analysis of fortified 
samples. The achieved limits of detection and quantification were 
comparable to those of instrumental methodologies. These 
immunoreagents and ELISAs could contribute to a wider spread 
of immunochemical assays as alternative and complementary 50 
approaches to modern analytical challenges. Based on the 
excellent immune response triggered by the synthesized hapten, 
work is in progress with the aim of generating monoclonal 
antibodies exhibiting even better analytical properties. 
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